Design Cloud

  • Home

  • About Us

    Company Profile HIstory Culture Honor
    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    Cardiovascular series Psychiatry series Hepatobiliary, Gastroenterology Series Respiratory series Anti-infective virus series Other series Large Infusion Series Huabao Tong Series Active Pharmaceutical Ingredient Series
    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    Academician Expert Workstation Medical Research and Industry Alliance
    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    General News Party group dynamics Employee activity
    • General News

    • Party group dynamics

    • Employee activity

  • HR

    Talent Strategy Company recruitment
    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

News

  • Home page

General News

Party group dynamics

Employee activity

Wanbangde Pharmaceutical Group Co., Ltd. – Soil Testing Report for Shangma Industrial Park, Shitang Town, Wenling City

Date:

01 Mar,2021


Wanbande Pharmaceutical Group Co., Ltd. – Soil Testing Report for Shangma Industrial Park, Shitang Town, Wenling City

The full text is attached. Click to download (1)

Previous page

The 2019 Outstanding Employees Recognition Ceremony of Wanbangde Pharmaceutical Concludes Successfully

Environmental Impact Assessment Information Announcement for the Technology Upgrade Project of Wanbangde Pharmaceutical Group Co., Ltd.

Next page

Related Recommendations

Image Name

2025/01/21

Good News | Wanbangde Pharmaceutical Group's WP103 (Huperzine A Injection) Receives U.S. FDA Approval for Clinical Trials

Image Name

2025/01/21

Good News | Wanbangde Pharmaceutical Group’s WP107 (Huperzine A Oral Solution) Receives U.S. FDA Approval for Clinical Trials

Image Name

2025/01/13

Good News | Wanbangde Pharmaceutical Group's Cefaclor Granules Pass Consistency Evaluation!

< 1234...78 > proceed page
  • Home

  • About Us

    • Company Profile

    • HIstory

    • Culture

    • Honor

  • Products

    • Cardiovascular series

    • Psychiatry series

    • Hepatobiliary, Gastroenterology Series

    • Respiratory series

    • Anti-infective virus series

    • Other series

    • Large Infusion Series

    • Huabao Tong Series

    • Active Pharmaceutical Ingredient Series

  • R&D

    • Academician Expert Workstation

    • Medical Research and Industry Alliance

  • News

    • General News

    • Party group dynamics

    • Employee activity

  • HR

    • Talent Strategy

    • Company recruitment

  • Contact us

  • 中文版

Image Name

Website Development: China Enterprise DynamicsTaizhou

Business license
浙ICP备10002622号-38